Results showed enhanced tumor retention of EGFR-targeted SPIONs with minimized systemic exposure, enhanced intra-tumoral SPION distribution via inhalation, and significant inhibition of in vivo tumor growth. The gene discussed is EGFR; the disease is neoplasm.